Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Daily Aspirin or Other Antiplatelet Therapy Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 27 Clinics in the SSM Health Dean Medical Group health system


The results below represent the care of 4,515 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
SSM Health Cancer Care

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Baraboo
N=442
99.10 %
View Historical Data
SSM Health Dean Medical Group - Barneveld

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Beaver Dam
N=220
98.64 %
View Historical Data
SSM Health Dean Medical Group - Columbus

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Deerfield

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Delavan

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Dodgeville

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Edgerton

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Evansville

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Fish Hatchery Rd, Madison
N=463
98.70 %
View Historical Data
SSM Health Dean Medical Group - Fort Atkinson
N=133
95.49 %
View Historical Data
SSM Health Dean Medical Group - Janesville
N=684
97.51 %
View Historical Data
SSM Health Dean Medical Group - Lake Delton

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Mineral Point

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - N. High Point Rd, Madison
N=469
97.44 %
View Historical Data
SSM Health Dean Medical Group - Oregon
N=144
97.22 %
View Historical Data
SSM Health Dean Medical Group - Portage
N=189
98.41 %
View Historical Data
SSM Health Dean Medical Group - S. Stoughton Rd, Madison
N=831
98.56 %
View Historical Data
SSM Health Dean Medical Group - Stoughton
N=203
96.06 %
View Historical Data
SSM Health Dean Medical Group - Sun Prairie
N=397
97.48 %
View Historical Data
SSM Health Dean Medical Group - Waterloo

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health Dean Medical Group - Waunakee
N=122
96.72 %
View Historical Data
SSM Health Dean Medical Group - Whitewater
N=115
96.52 %
View Historical Data
SSM Health Dean Medical Group - Wisconsin Dells
N=103
95.15 %
View Historical Data
SSM Health Outpatient Center

The number of patients or providers is too small for
purposes of reliably reporting performance
SSM Health St Mary's Hospital - Madison

The number of patients or providers is too small for
purposes of reliably reporting performance

There has been important evidence from clinical trials that further supports and broadens the merits of risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease.

Based on trials involving other secondary prevention therapies, the ACC and AHA recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions.

This measure shows the percentage of people 18 to 75 years of age with a diagnosis coronary or other atherosclerotic vascular disease who were prescribed oral antiplatelet therapy, unless contraindicated, in the measurement year.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.